Twist Bioscience (TWST) executive compensation, 2026 proxy

Emily M. Leproust, Ph.D., Chief Executive Officer and Chair of the Board, was paid $13.8M in 2025, up 81% from $7.6M the year before. The CEO-to-median-employee pay ratio was 73:1, on median employee pay of $188,208.

Filed
January 6, 2026
Annual meeting
February 5, 2026
Pay year
2025
Named executives
5
CEO total pay
$13.8M+81% vs prior year
CEO to median employee
73:1median $188,208
CEO pay in equity
87%$12M in awards
CEO Target Bonus %
100%Percentage of year-end base salary.
Median Employee Pay
$188,208Annual total compensation for fiscal 2025.
CEO Pay Ratio
73.2:1Ratio of CEO to median employee compensation.

How Ph.D. was paid

$13.8M in total for 2025, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.

Salary5%Stock awards87%Non-equity incentive7%All other compensation1%

Named executive officers

ExecutiveTotal
Emily M. Leproust, Ph.D.Chief Executive Officer and Chair of the Board$13,781,570
Adam LaponisChief Financial Officer$4,216,117
Patrick Finn, Ph.D.President and Chief Operating Officer$8,022,942
Paula GreenSenior Vice President of Human Resources$3,348,859
Dennis ChoChief Legal Officer and Corporate Secretary$3,621,076

What changed and why

  • $13.8MCEO total compensation increased to $13,781,570 in fiscal 2025 from $7,620,611 in fiscal 2024.
  • Annual cash bonuses were earned under the Cash Bonus Plan based on revenue, adjusted gross profit, and individual goals.
  • Equity awards in fiscal 2025 consisted of time-based RSUs and performance-based PRSUs.

About this page

Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.